The Financial Horizons
No Result
View All Result
  • Investing
  • Stock
  • Economy
  • Editor’s Pick
  • Latest News
  • Investing
  • Stock
  • Economy
  • Editor’s Pick
  • Latest News
No Result
View All Result
The Financial Horizons
No Result
View All Result
Home Latest News

Senate committee to vote on Dr. Oz’s nomination to run the Centers for Medicare and Medicaid Services

by
March 25, 2025
in Latest News
0
Senate committee to vote on Dr. Oz’s nomination to run the Centers for Medicare and Medicaid Services
0
SHARES
7
VIEWS
Share on FacebookShare on Twitter

The Senate Committee on Finance is set to vote later Tuesday afternoon on whether to advance President Donald Trump’s pick to lead the Centers for Medicare and Medicaid Services, Dr. Mehmet Oz, to a full Senate confirmation vote. 

The vote follows two hearings by the committee that probed Oz over his plans for the federal healthcare programs, his views on abortion, potential conflicts of interest in the healthcare industry and more.   

If confirmed, Oz would be in charge of nearly $1.5 trillion in federal healthcare spending. Medicare, a federal healthcare program for seniors aged 65 and up, currently provides coverage for about 65 million Americans, according to the Center for Medicare Advocacy. Medicaid, which assists people with low incomes, covers roughly 72 million Americans, according to Medicaid.gov.

A former heart surgeon who saw his fame rise through his appearances on daytime TV and 13 seasons of ‘The Dr Oz Show,’ Oz later transitioned into politics, launching an unsuccessful bid for Pennsylvania’s open Senate seat in 2022. He ultimately lost to John Fetterman, then the state’s lieutenant governor. 

Oz graduated from Harvard and received medical and business degrees from the University of Pennsylvania.

As the administrator of CMS, Oz would make decisions related to how the government covers procedures, hospital stays and medication within the federal healthcare programs, as well as the reimbursement rates at which healthcare providers get paid for their services.

Earlier this month, Trump’s pick to lead the NIH and FDA, Dr. Jay Bhattacharya and Dr. Marty Makary, respectively, were also approved in committee and are awaiting full confirmation votes in the Senate. 

Around the same time that Bhattacharya and Makary won committee approval, Trump withdrew his nomination of former Florida Rep. David Weldon to run the CDC, over fears he did not have the GOP support to clear full confirmation. 

On Monday, the Trump administration named Susan Monarez, acting director of the CDC, as its new nominee.

This post appeared first on FOX NEWS
Previous Post

Trump not planning to fire Waltz after national security text chain leak

Next Post

Dem senator calls for Waltz, Hegseth to resign as Gabbard says no classified material shared in Signal

Next Post
Dem senator calls for Waltz, Hegseth to resign as Gabbard says no classified material shared in Signal

Dem senator calls for Waltz, Hegseth to resign as Gabbard says no classified material shared in Signal

    Stay updated with the latest news, exclusive offers, and special promotions. Sign up now and be the first to know! As a member, you'll receive curated content, insider tips, and invitations to exclusive events. Don't miss out on being part of something special.


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Recent News

    ‘Another endless conflict’: Democrat echoes Trump’s anti-war stance as Middle East tensions escalate

    ‘Another endless conflict’: Democrat echoes Trump’s anti-war stance as Middle East tensions escalate

    June 16, 2025
    Supreme Court hands Ed Sheeran legal win in Marvin Gaye copyright fight

    Supreme Court hands Ed Sheeran legal win in Marvin Gaye copyright fight

    June 16, 2025
    Trump made millions on guitars, Bibles and watches with his name on them, disclosure reveals

    Trump made millions on guitars, Bibles and watches with his name on them, disclosure reveals

    June 16, 2025
    Could private security contractors be the ‘day after’ solution in Gaza?

    Could private security contractors be the ‘day after’ solution in Gaza?

    June 16, 2025
    • About us
    • Contact us
    • Privacy Policy
    • Terms & Conditions
    • About us
    • Contact us
    • Privacy Policy
    • Terms & Conditions

    Disclaimer: Thefinancialhorizons.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2025 thefinancialhorizons.com | All Rights Reserved

    No Result
    View All Result
    • Investing
    • Stock
    • Economy
    • Editor’s Pick
    • Latest News

    Disclaimer: Thefinancialhorizons.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2025 thefinancialhorizons.com | All Rights Reserved